URANIUM ROYALTY CORP(NASDAQ:UROY) stock Fundamental Analysis

Fundamental Rating

UROY gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 210 industry peers in the Oil, Gas & Consumable Fuels industry. UROY scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, UROY is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year UROY was profitable.

In the past year UROY has reported a negative cash flow from operations.

UROY had negative earnings in 4 of the past 5 years.

In the past 5 years UROY always reported negative operating cash flow.

1.2 Ratios

The Return On Assets of UROY (2.16%) is worse than 66.01% of its industry peers.

UROY's Return On Equity of 2.32% is on the low side compared to the rest of the industry. UROY is outperformed by 68.97% of its industry peers.

With a Return On Invested Capital value of 1.40%, UROY is not doing good in the industry: 78.33% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	2.16%
ROE	2.32%
ROIC	1.4%

ROA(3y)-0.67%

ROA(5y)-1.53%

ROE(3y)-0.79%

ROE(5y)-1.61%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

UROY has a Profit Margin of 16.99%. This is in the better half of the industry: UROY outperforms 61.08% of its industry peers.

Looking at the Operating Margin, with a value of 13.88%, UROY is doing worse than 60.10% of the companies in the same industry.

With a Gross Margin value of 38.53%, UROY perfoms like the industry average, outperforming 44.83% of the companies in the same industry.

		Industry Rank	Sector Rank
OM	13.88%
PM (TTM)	16.99%
GM	38.53%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), UROY is destroying value.

Compared to 1 year ago, UROY has more shares outstanding

The number of shares outstanding for UROY has been increased compared to 5 years ago.

Compared to 1 year ago, UROY has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 12.96 indicates that UROY is not in any danger for bankruptcy at the moment.

The Altman-Z score of UROY (12.96) is better than 96.55% of its industry peers.

UROY has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.

With a decent Debt to Equity ratio value of 0.07, UROY is doing good in the industry, outperforming 79.80% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.07
Debt/FCF	N/A
Altman-Z	12.96

ROIC/WACC0.18

WACC7.86%

2.3 Liquidity

UROY has a Current Ratio of 11.93. This indicates that UROY is financially healthy and has no problem in meeting its short term obligations.

Looking at the Current ratio, with a value of 11.93, UROY belongs to the top of the industry, outperforming 95.57% of the companies in the same industry.

UROY has a Quick Ratio of 1.05. This is a normal value and indicates that UROY is financially healthy and should not expect problems in meeting its short term obligations.

The Quick ratio of UROY (1.05) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Current Ratio	11.93
Quick Ratio	1.05

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

UROY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 241.33%, which is quite impressive.

The Revenue has grown by 31.26% in the past year. This is a very strong growth!

EPS 1Y (TTM)241.33%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-100%

Revenue 1Y (TTM)31.26%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%-28.82%

3.2 Future

UROY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.90% yearly.

Based on estimates for the next years, UROY will show a very strong growth in Revenue. The Revenue will grow by 20.80% on average per year.

EPS Next Y-121.43%

EPS Next 2Y-53.71%

EPS Next 3Y41.9%

EPS Next 5YN/A

Revenue Next Year-45.03%

Revenue Next 2Y-23.47%

Revenue Next 3Y20.8%

Revenue Next 5YN/A

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

UROY is valuated quite expensively with a Price/Earnings ratio of 53.00.

UROY's Price/Earnings ratio is a bit more expensive when compared to the industry. UROY is more expensive than 72.41% of the companies in the same industry.

UROY's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 29.62.

With a Price/Forward Earnings ratio of 198.65, UROY can be considered very expensive at the moment.

Based on the Price/Forward Earnings ratio, UROY is valued a bit more expensive than the industry average as 73.89% of the companies are valued more cheaply.

The average S&P500 Price/Forward Earnings ratio is at 22.70. UROY is valued rather expensively when compared to this.

		Industry Rank	Sector Rank
PE	53
Fwd PE	198.65

4.2 Price Multiples

UROY's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. UROY is more expensive than 79.31% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	69.29

4.3 Compensation for Growth

A more expensive valuation may be justified as UROY's earnings are expected to grow with 41.90% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-53.71%

EPS Next 3Y41.9%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for UROY!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

URANIUM ROYALTY CORP

NASDAQ:UROY (2/21/2025, 8:00:01 PM)

Premarket: 2.17 +0.05 (+2.36%)

2.12

-0.14 (-6.19%)

Chartmill FA Rating

GICS SectorEnergy

GICS IndustryGroupEnergy

GICS IndustryOil, Gas & Consumable Fuels

Earnings (Last)12-12 2024-12-12/amc

Earnings (Next)03-12 2025-03-12

Inst Owners25.1%

Inst Owner Change-83.99%

Ins Owners2.18%

Ins Owner ChangeN/A

Market Cap283.21M

Analysts80

Price Target5.08 (139.62%)

Short Float %12.62%

Short Ratio5.9

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)19.24%

PT rev (3m)16.97%

EPS NQ rev (1m)0%

EPS NQ rev (3m)N/A

EPS NY rev (1m)-137.5%

EPS NY rev (3m)-137.5%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)-31.87%

Revenue NY rev (3m)-35.67%

Valuation

		Industry Rank	Sector Rank
PE	53
Fwd PE	198.65
P/S	10.5
P/FCF	N/A
P/OCF	N/A
P/B	1.43
P/tB	1.43
EV/EBITDA	69.29

EPS(TTM)0.04

EY1.89%

EPS(NY)0.01

Fwd EY0.5%

FCF(TTM)-0.64

FCFYN/A

OCF(TTM)-0.58

OCFYN/A

SpS0.2

BVpS1.48

TBVpS1.48

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	2.16%
ROE	2.32%
ROCE	1.89%
ROIC	1.4%
ROICexc	1.51%
ROICexgc	1.51%
OM	13.88%
PM (TTM)	16.99%
GM	38.53%
FCFM	N/A

ROA(3y)-0.67%

ROA(5y)-1.53%

ROE(3y)-0.79%

ROE(5y)-1.61%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0.13

Health

		Industry Rank	Sector Rank
Debt/Equity	0.07
Debt/FCF	N/A
Debt/EBITDA	3.55
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	11.93
Quick Ratio	1.05
Altman-Z	12.96

F-Score4

WACC7.86%

ROIC/WACC0.18

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)241.33%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-100%

EPS Next Y-121.43%

EPS Next 2Y-53.71%

EPS Next 3Y41.9%

EPS Next 5YN/A

Revenue 1Y (TTM)31.26%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%-28.82%

Revenue Next Year-45.03%

Revenue Next 2Y-23.47%

Revenue Next 3Y20.8%

Revenue Next 5YN/A

EBIT growth 1Y761.64%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-165.28%

EBIT Next 3Y-58.92%

EBIT Next 5YN/A

FCF growth 1Y-161.85%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-136.76%

OCF growth 3YN/A

OCF growth 5YN/A

URANIUM ROYALTY CORP (UROY) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens